EditorialPortal Hypertension in Primary Biliary Cirrhosis: A Potentially Reversible Harbinger of Demise
References (16)
- et al.
Portal hypertension and primary biliary cirrhosis: effect of long-term ursodeoxycholic acid treatment
Gastroenterology
(2008) - et al.
Nodular regenerative hyperplasia of the liver in early histological stages of primary biliary cirrhosis
Gastroenterology
(1992) - et al.
Ursodeoxycholic acid delays the onset of esophageal varices in primary biliary cirrhosis
Mayo Clin Proc
(1997) - et al.
A randomized double-blind placebo-controlled trial of ursodeoxycholic acid in primary biliary cirrhosis
Hepatology
(1995) - et al.
Long term effects of ursodeoxycholic acid in primary biliary cirrhosis: results of a double-blind controlled multicentric trial
J Hepatol
(2000) - et al.
A placebo-controlled trial of primary biliary cirrhosis treatment with colchicine and ursodeoxycholic acid
Gastroenterology
(1995) - et al.
Ursodeoxycholic acid in the treatment of primary biliary cirrhosis
Gastroenterology
(1994) - et al.
Bleeding oesophageal varices as the presenting feature in primary biliary cirrhosis
Lancet
(1969)
There are more references available in the full text version of this article.
Cited by (4)
Granulomatous Diseases of the Liver
2012, Zakim and Boyer's HepatologyUrsodeoxycholic Acid in Liver Cirrhosis: An Evidence-Based Review
2022, Pharmacotherapy for Liver Cirrhosis and Its ComplicationsPortal hypertension in primary biliary cholangitis: prevalence, natural history and histological correlates
2021, European Journal of Gastroenterology and HepatologyPrimary biliary cirrhosis
2009, Seminars in Immunopathology
The author discloses no conflicts.
Copyright © 2008 AGA Institute. Published by Elsevier Inc. All rights reserved.